Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
DR

Didier Roche — 17 Patents

Merck: 12 patents #936 of 9,382Top 10%
U1Universite Claude Bernad Lyon 1: 2 patents #80 of 791Top 15%
CNCNRS: 2 patents #1,756 of 11,908Top 15%
POPoxel: 2 patents #5 of 31Top 20%
Novartis Ag: 1 patents #2,882 of 5,128Top 60%
BPBayer Pharma: 1 patents #440 of 819Top 55%
Écully, FR: #10 of 198 inventorsTop 6%
Overall (All Time): #263,971 of 4,157,543Top 7%
17 Patents All Time
Didier Roche has been granted 17 US patents while listed as an inventor at Merck. The first was granted in 2002 and the most recent in May 2020. Didier Roche ranks #263,971 of 4,157,543 US inventors in our database (top 6.3%). Patent records list Didier Roche in Écully, FR.

Issued Patents All Time

Showing 1–17 of 17 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
10654818 Furane derivatives as inhibitors of ATAD2 Markus Berger, Jan Hübner, Antonius Ter Laak, Matyas Gorjanacz, Amaury Ernesto Fernandez-Montalvan +1 more 2020-05-19
10071108 Methods and pharmaceutical compositions for the treatment of hepatitis b virus infection Patrice Andre, Vincent Lotteau, Pauline Radreau, Marine Gilardone, Amaury Patin +2 more 2018-09-11
9895380 Methods and pharmaceutical compositions for the treatment of hepatitis B virus infection Patrice Andre, Vincent Lotteau, Pauline Radreau, Marine Gilardone, Amaury Patin +2 more 2018-02-20
8765728 [1,5]-diazocin derivatives Fabrice Chimienti, Martin Ohsten 2014-07-01
8586577 Diazepane acetamide derivatives as selective 11B-HSD1 inhibitors Denis Carniato, Caroline Leriche, Christine Charon, Liliane Doare 2013-11-19 $50,784,000
8575161 Benzofurane, benzothiophene, benzothiazol derivatives as FXR modulators Gisèle Mautino, Ingo Kober, Francis Contard, Serge Christmann-Franck, Saumitra Sengupta +2 more 2013-11-05 $76,609,000
8546575 NIP thiazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydroge-nase-1 Caroline Leriche, Denis Carniato, Christine Charon, Liliane Doare 2013-10-01 $68,208,000
8486964 Fused pyrrolidino-cyclopropane derivatives as selective 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors Eric Valeur, Franck Lepifre, Denis Carniato, Serge Christmann-Franck, Fabien SCHMIDLIN 2013-07-16 $58,549,000
8470849 7-azaindole derivatives as selective 11-β-hydroxysteroid dehydrogenase type 1 inhibitors Denis Carniato, Sophie Hallakou-Bozec, Melanie Schultz 2013-06-25 $46,267,000
8466200 2-adamantylurea derivatives as selective 11β-HSD1 inhibitors Denis Carniato, Christine Charon, Johannes Gleitz, Bjoern Hock 2013-06-18 $99,229,000
8242107 Diazepane-acetamide derivatives as selective 11β-HSD1 inhibitors Denis Carniato, Caroline Leriche, Christine Charon, Liliane Doare 2012-08-14 $48,825,000
8188288 2-adamantylurea derivatives as selective 11beta-HSD1 inhibitors Denis Carniato, Christine Charon, Johannes Gleitz, Bjoern Hock 2012-05-29 $53,466,000
8183265 2-adamantyl-butyramide derivatives as selective 11β-HSD1 inhibitors Denis Carniato, Liliane Doare, Christine Charon, Caroline Leriche 2012-05-22 $103,671,000
7754740 1H-indole-3-carboxylic acid derivatives and their use as PPAR agonists Nathalie Adje, Stéphane Yvon 2010-07-13 $47,079,000
7582656 Guanidine derivatives and therapeutic uses thereof Bruno Roux, Isabelle Berard 2009-09-01 $61,988,000
7482484 Carboxylic acids and derivatives for the treatment of and preventing diabetes and dyslipidaemia Nathalie Adje, Michel Brunet, Jean-Jacques Zeiller, Stéphane Yvon, Valérie Guyard-Dangremont +4 more 2009-01-27 $37,804,000
6399599 Substituted 2-oxo-1,4-diazacycloalkanes Rainer Albert, Josef Gottfried Meingassner, Sompong Wattanasin, Gabriele Weitz-Schmidt, Karl Welzenbach +3 more 2002-06-04 $8,550,000